The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Fee authorized using an esketamine nasal spready under the model identify Spravato to take care of depression. On the other hand, as of 2021, ketamine has not been accepted by the FDA to treat depression or https://tallentyreh665aly8.activosblog.com/profile